Erythromycin B

• Description:

  Erythromycin B has anti-malarial activity and effectively inhibits the asexual reproduction of Plasmodium falciparum[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H319

• Target:

  Parasite

• Type:

  Natural Products

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/erythromycin-b.html

• Smiles:

  C[C@@H] ([C@@H] ([C@H] (C (O[C@@H] ([C@@H] ([C@@H] ([C@H] (C ([C@@H] (C[C@]1 (O) C) C) =O) C) O) C) CC) =O) C) O[C@H]2C[C@] (C) ([C@H] ([C@@H] (O2) C) O) OC) [C@H]1O[C@H]3[C@@H] ([C@H] (C[C@H] (O3) C) N (C) C) O

• Molecular Formula:

  C37H67NO12

• Molecular Weight:

  717.93

• Precautions:

  P264-P280-P305+P351+P338

• References & Citations:

  [1]Pranab K Bhadra, et al. Selected Derivatives of Erythromycin B- In Silico and Anti-Malarial Studies. Materials (Basel) . 2021 Nov 18;14 (22) :6980.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Natural Products

• Clinical Information:

  No Development Reported

• CAS Number:

  527-75-3